首页 >
法规速递
-
Document: Scientific recommendations on classification of advanced therapy medicinal products-2025/11/25
2025-11-26查看详情 > -
Page: Extended EudraVigilance medicinal product dictionary (XEVMPD) training-2025/12/17
2025-12-18查看详情 > -
Document: Minutes – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 17 December 2025-2026/2/2
2026-02-03查看详情 > -
Page: High-risk medical devices: consultation procedures-2026/3/10
2026-03-11查看详情 > -
Page: Establishing maximum residue limits for veterinary medicines-2026/4/8
2026-04-09查看详情 > -
国家药监局关于同意湖北、湖南省药监局开展优化药品补充申请审评审批程序改革试点的批复-2026/5/27
2026-05-28查看详情 > -
Document: Dates of 2027 SAWP meetings and submission deadlines Scientific advice, protocol assistance, qualification of biomarkers and parallel HTACG/EMA Joint Scientific Consultation requests-2026/7/9
2026-07-10查看详情 > -
Document: Presentation - Challenges and opportunities in medicines and medical devices development-2026/8/13
2026-08-14查看详情 > -
国家药监局关于发布《药品上市许可持有人落实药品质量安全主体责任监督管理规定》的公告（2022年第126号）
2022-12-30查看详情 > -
国家药监局综合司关于同意北京市药品检验研究院增加生物制品批签发证明文件授权签发人的复函-2023/7/17
2023-07-21查看详情 >
